Argentex Group PLC Investor Presentation of FY 2023 Results

RNS Number : 3132R

Argentex Group PLC

06 June 2024

 

                                        COMPANY REGISTRATION NUMBER 11965856

 

 

 6 June 2024

 

Argentex Group PLC

  

("Argentex")

 

Investor presentation of FY 2023 results

 

 

Argentex Group PLC (AIM: AGFX), the global specialist in currency risk management and alternative banking, is pleased to announce that Jim Ormonde (CEO) and Guy Rudolph (Interim CFO) will host a live presentation on the FY23 Final Results and Strategy Update via the Investor Meet Company platform at 11:00 on 18 June 2024.

 

The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 9:00 on 17 June 2024, or at any time during the live presentation.

 

Investors who already follow Argentex on the Investor Meet Company platform will automatically be invited. Those wishing to sign up for free, and meet Argentex, can do so via https://www.investormeetcompany.com/argentex-group-plc/register-investor

 

For further information, please contact:

 

Argentex Group PLC

Jim Ormonde - Chief Executive Officer

Guy Rudolph - Interim Chief Financial Officer

[e-mail]

 

Teneo (Financial PR)

James Macey-White / Victoria Boxall / Rashida Salemahomed

[e-mail], 020 7260 2700

 

Singer Capital Markets (Nominated Adviser and Broker)

Tom Salvesen / James Maxwell / Angus Campbell

020 7496 3000

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

MSCUPUAGQUPCGMA